{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T21:11:52Z","timestamp":1789593112145,"version":"build-2803163510"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T00:00:00Z","timestamp":1746662400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"University Hospital of Salamanca, IBSAL, Cancer Research Center-IBMCC (USAL-CSIC), CIBERONC, Salaman"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neoplasia"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.neo.2025.101177","type":"journal-article","created":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T11:59:40Z","timestamp":1747223980000},"page":"101177","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["MYC alterations in multiple myeloma: Genetic insights and prognostic impact"],"prefix":"10.1016","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-0109-6488","authenticated-orcid":false,"given":"Sara","family":"Crist\u00f3bal-Vargas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9410-1205","authenticated-orcid":false,"given":"Myriam","family":"Cuadrado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5834-9510","authenticated-orcid":false,"given":"Norma C","family":"Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.neo.2025.101177_bib0001","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1182\/blood-2007-10-078022","article-title":"Multiple myeloma","volume":"111","author":"Kyle","year":"2008","journal-title":"Blood"},{"issue":"S1","key":"10.1016\/j.neo.2025.101177_bib0002","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/hon.2586","article-title":"Multiple myeloma: every year a new standard?","volume":"37","author":"Rajkumar","year":"2019","journal-title":"Hematol. Oncol."},{"key":"10.1016\/j.neo.2025.101177_bib0003","first-page":"676","article-title":"Multiple myeloma epidemiology and survival: a unique malignancy","volume":"43","author":"Kazandjian","year":"2016"},{"key":"10.1016\/j.neo.2025.101177_bib0005","series-title":"Roadmap to cure multiple myeloma. Vol. 100, Cancer Treatment Reviews","author":"Rodriguez-Otero","year":"2021"},{"key":"10.1016\/j.neo.2025.101177_bib0006","first-page":"1","article-title":"Genetic abnormalities in multiple myeloma: prognostic and therapeutic implications. Vol. 10","author":"IJ","year":"2021","journal-title":"Cells. MDPI"},{"issue":"3","key":"10.1016\/j.neo.2025.101177_bib0007","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/gcc.10211","article-title":"Heterogeneous pattern of chromosomal breakpoints involving the MYC locus in multiple myeloma","volume":"37","author":"Fabris","year":"2003","journal-title":"Genes Chromosomes Cancer"},{"issue":"10","key":"10.1016\/j.neo.2025.101177_bib0008","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.1182\/blood.V98.10.3082","article-title":"Rearrangements of the c-myc oncogene are present in 15% of primary human multiple myeloma tumors","volume":"98","author":"Avet-Loiseau","year":"2001","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.neo.2025.101177_bib0009","doi-asserted-by":"crossref","first-page":"e191","DOI":"10.1038\/bcj.2014.13","article-title":"Translocations at 8q24 juxtapose MYC with genes that harbor superenhancers resulting in overexpression and poor prognosis in myeloma patients","volume":"4","author":"Walker","year":"2014","journal-title":"Blood Cancer J."},{"issue":"8","key":"10.1016\/j.neo.2025.101177_bib0010","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1038\/leu.2014.70","article-title":"Promiscuous MYC locus rearrangements hijack enhancers but mostly super-enhancers to dysregulate MYC expression in multiple myeloma","volume":"28","author":"Affer","year":"2014","journal-title":"Leukemia"},{"issue":"12","key":"10.1016\/j.neo.2025.101177_bib0011","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/s41408-019-0255-z","article-title":"Mate pair sequencing outperforms fluorescence in situ hybridization in the genomic characterization of multiple myeloma","volume":"9","author":"Smadbeck","year":"2019","journal-title":"Blood Cancer J"},{"issue":"4","key":"10.1016\/j.neo.2025.101177_bib0012","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.3324\/haematol.2019.217927","article-title":"Microhomology-mediated end joining drives complex rearrangements and overexpression of MYC and PVT1 in multiple myeloma","volume":"105","author":"Mikulasova","year":"2020","journal-title":"Haematologica"},{"issue":"19","key":"10.1016\/j.neo.2025.101177_bib0013","doi-asserted-by":"crossref","first-page":"5430","DOI":"10.1158\/1078-0432.CCR-21-0005","article-title":"The prognostic role of MYC structural variants identified by NGS and FISH in multiple myeloma","volume":"27","author":"Sharma","year":"2021","journal-title":"Clinic. Cancer Res"},{"key":"10.1016\/j.neo.2025.101177_bib0014","doi-asserted-by":"crossref","DOI":"10.1111\/ejh.13141","article-title":"Myc protein overexpression is a feature of progression and adverse prognosis in multiple myeloma","author":"M\u00f8ller","year":"2018","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.neo.2025.101177_bib0015","article-title":"MYC: a multipurpose oncogene with prognostic and therapeutic implications in blood malignancies","volume":"14","author":"Ahmadi","year":"2021","journal-title":"J. Hematol. Oncol"},{"issue":"24","key":"10.1016\/j.neo.2025.101177_bib0016","doi-asserted-by":"crossref","first-page":"6581","DOI":"10.1158\/1078-0432.CCR-20-2283","article-title":"Implications of MYC rearrangements in newly diagnosed multiple myeloma","volume":"26","author":"Abdallah","year":"2020","journal-title":"Clinic. Cancer Res"},{"issue":"12","key":"10.1016\/j.neo.2025.101177_bib0017","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1182\/blood-2011-08-371567","article-title":"Addiction to c-MYC in multiple myeloma","volume":"120","author":"Holien","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.neo.2025.101177_bib0018","first-page":"22","article-title":"MYC on the path to cancer. Vol. 149","author":"Dang","year":"2012","journal-title":"Cell. Elsevier B.V."},{"key":"10.1016\/j.neo.2025.101177_bib0019","article-title":"Therapeutic inhibition of myc in cancer. Structural bases and computer-aided drug discovery approaches","volume":"20","author":"Carabet","year":"2019","journal-title":"Int. J. Molecular Sci. MDPI AG"},{"key":"10.1016\/j.neo.2025.101177_bib0020","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41571-021-00549-2","article-title":"The MYC oncogene \u2014 The grand orchestrator of cancer growth and immune evasion","volume":"19","author":"Dhanasekaran","year":"2022","journal-title":"Nat. Rev. Clinic. Oncol"},{"key":"10.1016\/j.neo.2025.101177_bib0021","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/s41568-021-00367-9","article-title":"MYC protein interactors in gene transcription and cancer","volume":"21","author":"Lourenco","year":"2021","journal-title":"Nature Reviews Cancer"},{"key":"10.1016\/j.neo.2025.101177_bib0022","first-page":"1295","article-title":"Targeting MYC in multiple myeloma. Vol. 32","author":"Jovanovi\u0107","year":"2018","journal-title":"Leukemia. Nat. Publish. Group"},{"issue":"1","key":"10.1016\/j.neo.2025.101177_bib0023","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/s41392-021-00500-y","article-title":"Alternative approaches to target Myc for cancer treatment","volume":"6","author":"Wang","year":"2021","journal-title":"Signal. Transduct. Target. Ther"},{"key":"10.1016\/j.neo.2025.101177_bib0024","doi-asserted-by":"crossref","first-page":"103756","DOI":"10.1016\/j.ebiom.2021.103756","article-title":"Therapeutic targeting of \u201cundruggable\u201d MYC","volume":"75","author":"Llombart","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.neo.2025.101177_bib0025","series-title":"MYC inhibitors in multiple myeloma. Vol. 4, Cancer Drug Resistance","first-page":"842","author":"Mart\u00ednez-Mart\u00edn","year":"2021"},{"issue":"19","key":"10.1016\/j.neo.2025.101177_bib0026","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15194687","article-title":"Optical genome mapping reveals the complex genetic landscape of myeloma","volume":"15","author":"Gigu\u00e8re","year":"2023","journal-title":"Cancers. (Basel)"},{"issue":"12","key":"10.1016\/j.neo.2025.101177_bib0027","doi-asserted-by":"crossref","DOI":"10.3390\/genes12121958","article-title":"Optical genome mapping in routine Human genetic diagnostics-its advantages and limitations","volume":"12","author":"Dremsek","year":"2021","journal-title":"Genes. (Basel)"},{"issue":"24","key":"10.1016\/j.neo.2025.101177_bib0028","doi-asserted-by":"crossref","first-page":"4173","DOI":"10.1158\/0008-5472.CAN-24-1440","article-title":"Selective enhancer gain-of-function deregulates MYC expression in multiple myeloma","volume":"84","author":"Rahmat","year":"2024","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.neo.2025.101177_bib0029","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/s41408-024-01147-y","article-title":"Characterization of MYC rearrangements in multiple myeloma: an optical genome mapping approach","volume":"14","author":"Yoon","year":"2024","journal-title":"Blood Cancer J"},{"issue":"40","key":"10.1016\/j.neo.2025.101177_bib0030","doi-asserted-by":"crossref","first-page":"5611","DOI":"10.1038\/sj.onc.1204641","article-title":"Chromosome translocations in multiple myeloma","volume":"20","author":"Bergsagel","year":"2001","journal-title":"Oncogene"},{"issue":"9\u201310","key":"10.1016\/j.neo.2025.101177_bib0031","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.dnarep.2006.05.012","article-title":"Distinguishing primary and secondary translocations in multiple myeloma","volume":"5","author":"Gabrea","year":"2006","journal-title":"DNa Repair. (Amst)"},{"issue":"1","key":"10.1016\/j.neo.2025.101177_bib0032","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1038\/s41467-019-09555-6","article-title":"Multiple myeloma immunoglobulin lambda translocations portend poor prognosis","volume":"10","author":"Barwick","year":"2019","journal-title":"Nat. Commun"},{"issue":"2","key":"10.1016\/j.neo.2025.101177_bib0033","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nrclinonc.2016.122","article-title":"Genomic complexity of multiple myeloma and its clinical implications","volume":"14","author":"Manier","year":"2017","journal-title":"Nat. Rev. Clin. Oncol"},{"issue":"7","key":"10.1016\/j.neo.2025.101177_bib0034","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/gcc.20563","article-title":"Secondary genomic rearrangements involving immunoglobulin or MYC loci show similar prevalences in hyperdiploid and nonhyperdiploid myeloma tumors","volume":"47","author":"Gabrea","year":"2008","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.neo.2025.101177_bib0035","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/jncimonographs\/lgn011","article-title":"Characterization of MYC translocations in multiple myeloma cell lines","author":"Dib","year":"2008","journal-title":"J. Natl. Cancer Inst. Monogr"},{"issue":"1","key":"10.1016\/j.neo.2025.101177_bib0036","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1073\/pnas.97.1.228","article-title":"Diverse karyotypic abnormalities of the c-myc locus associated with c-myc dysregulation and tumor progression in multiple myeloma","volume":"97","author":"Shou","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U S. A"},{"issue":"6","key":"10.1016\/j.neo.2025.101177_bib0037","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1182\/blood-2018-03-840132","article-title":"Identification of novel mutational drivers reveals oncogene dependencies in multiple myeloma","volume":"132","author":"Walker","year":"2018","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.neo.2025.101177_bib0038","doi-asserted-by":"crossref","DOI":"10.1016\/j.beha.2020.101153","article-title":"Genomic profiling of multiple myeloma: new insights and modern technologies","volume":"33","author":"Hultcrantz","year":"2020","journal-title":"Best. Pract. Res. Clin. Haematol"},{"issue":"6","key":"10.1016\/j.neo.2025.101177_bib0039","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1038\/leu.2011.53","article-title":"Clinical and biological implications of MYC activation: a common difference between MGUS and newly diagnosed multiple myeloma","volume":"25","author":"Chng","year":"2011","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.neo.2025.101177_bib0040","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ccr.2008.01.007","article-title":"AID-dependent activation of a MYC transgene induces multiple myeloma in a conditional mouse model of post-germinal center malignancies","volume":"13","author":"Chesi","year":"2008","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/j.neo.2025.101177_bib0041","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/s41591-022-02178-3","article-title":"Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myeloma","volume":"29","author":"Larrayoz","year":"2023","journal-title":"Nat. Med"},{"issue":"2","key":"10.1016\/j.neo.2025.101177_bib0042","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1182\/blood-2012-02-412783","article-title":"Drug response in a genetically engineered mouse model of multiple myeloma is predictive of clinical efficacy","volume":"120","author":"Chesi","year":"2012","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.neo.2025.101177_bib0043","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/s41375-019-0543-4","article-title":"MYC dysregulation in the progression of multiple myeloma","volume":"34","author":"Misund","year":"2020","journal-title":"Leukemia"},{"issue":"21","key":"10.1016\/j.neo.2025.101177_bib0044","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1200\/JCO.20.00437","article-title":"Genomic profiling of smoldering multiple myeloma identifies patients at a high risk of disease progression","volume":"38","author":"Bustoros","year":"2020","journal-title":"J. Clin. Oncol"},{"issue":"8","key":"10.1016\/j.neo.2025.101177_bib0045","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.3324\/haematol.2013.087809","article-title":"Transcriptome analysis reveals molecular profiles associated with evolving steps of monoclonal gammopathies","volume":"99","author":"L\u00f3pez-Corral","year":"2014","journal-title":"Haematologica"},{"issue":"6","key":"10.1016\/j.neo.2025.101177_bib0046","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1097\/PAS.0000000000000213","article-title":"MYC protein expression is detected in plasma cell myeloma but not in monoclonal gammopathy of undetermined significance (MGUS)","volume":"38","author":"Xiao","year":"2014","journal-title":"Am. J. Surg. Pathol"},{"issue":"1","key":"10.1016\/j.neo.2025.101177_bib0047","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41467-020-20524-2","article-title":"The molecular make up of smoldering myeloma highlights the evolutionary pathways leading to multiple myeloma","volume":"12","author":"Boyle","year":"2021","journal-title":"Nat. Commun"},{"issue":"7","key":"10.1016\/j.neo.2025.101177_bib0048","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.3324\/haematol.2008.004440","article-title":"Loss of 1p and rearrangement of MYC are associated with progression of smouldering myeloma to myeloma: sequential analysis of a single case","volume":"94","author":"Chiecchio","year":"2009","journal-title":"Haematologica"},{"issue":"8","key":"10.1016\/j.neo.2025.101177_bib0049","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1182\/blood-2006-08-040410","article-title":"Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du My\u00e9lome","volume":"109","author":"Avet-Loiseau","year":"2007","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.neo.2025.101177_bib0050","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.7194","article-title":"Myc rearrangement redefines the stratification of high-risk multiple myeloma","volume":"13","author":"Jin","year":"2024","journal-title":"Cancer Med"},{"issue":"11","key":"10.1016\/j.neo.2025.101177_bib0051","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1080\/10428194.2016.1187275","article-title":"Overexpression of c-myc is associated with adverse clinical features and worse overall survival in multiple myeloma","volume":"57","author":"Szabo","year":"2016","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.neo.2025.101177_bib0052","series-title":"Targeting \u201cundruggable\u201d c-Myc protein by synthetic lethality. Vol. 15, Frontiers of Medicine","first-page":"541","author":"Wang","year":"2021"},{"issue":"3","key":"10.1016\/j.neo.2025.101177_bib0053","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.tips.2020.11.014","article-title":"Capitalizing on synthetic lethality of MYC to treat cancer in the digital age","volume":"42","author":"Thng","year":"2021","journal-title":"Trends. Pharmacol. Sci"},{"issue":"2","key":"10.1016\/j.neo.2025.101177_bib0054","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2174\/1568009615666150121162921","article-title":"MYC-mediated synthetic lethality for treating tumors","volume":"15","author":"Li","year":"2015","journal-title":"Curr. Cancer Drug Targets"},{"issue":"1","key":"10.1016\/j.neo.2025.101177_bib0055","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2174\/1568009615666150105120055","article-title":"MYC-mediated synthetic lethality for treatment of hematological malignancies","volume":"15","author":"Li","year":"2015","journal-title":"Curr. Cancer Drug Targets"}],"container-title":["Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558625000569?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558625000569?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T15:18:35Z","timestamp":1751469515000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476558625000569"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":54,"alternative-id":["S1476558625000569"],"URL":"https:\/\/doi.org\/10.1016\/j.neo.2025.101177","relation":{},"ISSN":["1476-5586"],"issn-type":[{"value":"1476-5586","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MYC alterations in multiple myeloma: Genetic insights and prognostic impact","name":"articletitle","label":"Article Title"},{"value":"Neoplasia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neo.2025.101177","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101177"}}